Results 201 to 210 of about 5,178,954 (288)

Effective and new technologies in kidney tissue engineering. [PDF]

Front Bioeng Biotechnol
Rayat Pisheh H, Haghdel M, Jahangir M, Hoseinian MS, Rostami Yasuj S, Sarhadi Roodbari A.   +5 more
europepmc   +1 more source

Optimization and New Technologies Implementation: Java Application for Data Transmission [PDF]

, 2013
Konograi, N.A., Morozkin, Konstantin, Poperechna, N.V.   +2 more
core  

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

New Technologies and Digital Health Tools in Patients With Solid Tumors and Hematological Malignancies: Cross-Sectional Multicenter Survey Study.

JMIR Cancer
Lopez-Garcia A, Diaz-Aizpun C, Gallego-Diaz B, Miranda-Castillo C, Yuste-Platero M, Beltran-Alvarez P, Carames-Sanchez C, Garcia-Foncillas J, Llamas-Sillero P, Del Olmo-Rodriguez M, Short-Apellaniz J, Pfang B, Arcos-Campillo J, Cordoba R.   +13 more
europepmc   +1 more source

Assessing the Impact of New Technologies on Managing Chronic Respiratory Diseases. [PDF]

J Clin Med
Graña-Castro O, Izquierdo E, Piñas-Mesa A, Menasalvas E, Chivato-Pérez T.   +4 more
europepmc   +1 more source

Redox regulation meets metabolism: targeting PRDX2 to prevent hepatocellular carcinoma

Molecular Oncology, EarlyView.
PRDX2 acts as a central redox hub linking metabolic dysfunction‐associated steatohepatitis (MASH) to hepatocellular carcinoma (HCC). In normal hepatocytes, PRDX2 maintains redox balance and metabolic homeostasis under oxidative stress. In contrast, during malignant transformation, PRDX2 promotes oncogenic signaling, stemness, and tumor initiation ...
Naroa Goikoetxea‐Usandizaga, María Luz Martinez‐Chantar, Carolina Conter   +2 more
wiley   +1 more source

Preliminary Research: Effectiveness of an Intervention Program Based on New Technologies for the Improvement of Cognitive and Motor Processes in Children and Adolescents with ADHD: A Randomized Controlled Trial. [PDF]

Eur J Investig Health Psychol Educ
Caro-Puértolas B, Báez-Tavero I, Lemus-Corchero L, Rodríguez-Ruiz L, Cerezo-Casillas CE, Cosa-Aguirre AI, Apolo-Arenas MD, Caña-Pino A.   +7 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Using New Technologies to Analyze Gut Microbiota and Predict Cancer Risk. [PDF]

Cells
Hemmati MA, Monemi M, Asli S, Mohammadi S, Foroozanmehr B, Haghmorad D, Oksenych V, Eslami M.   +7 more
europepmc   +1 more source